Zou, K., Koh, T., Wolfe, H., Awan, F. (2025). Acalabrutinib monotherapy versus acalabrutinib plus obinutuzumab combination therapy in treatment-naïve chronic lymphocytic leukemia: A ‘real-world’ study of efficacy and safety at a tertiary academic medical center. Blood. https://doi.org/10.1182/blood-2025-4558